Miraqules
PrivateLast Round
Accelerator
Jul 10, 2023
Est. Valuation
$1.8M
Total Funding Raised
$1.02M
Company Overview
Miraqules operates in Healthcare & Life Sciences and is based in Bangalore. Its latest recorded funding round was an Accelerator round in July 2023.
Miraqules is a healthcare and life sciences company that develops and manufactures nano-biopolymer hemostatic solutions for rapid hemorrhage control.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Advanced Materials, Defense Tech
Business Model
B2G
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Miraqules Comparables
Compare Miraqules with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CELOX Medical | 83% | |
| Axio Biosolutions | 79% | |
| Cresilon | 78% |
For institutional investors. Book with your work email.
Miraqules Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jul 10, 2023 | ||||
| Early Funding | Mar 31, 2022 | ||||
| Grant | Oct 21, 2021 | ||||
| Grant | Sep 1, 2020 | ||||
| Grant | Jan 1, 2020 | ||||
Grant | Oct 1, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Miraqules Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Biotechnology Industry Research Assistance Council | Grant, Early Funding |
| Defence Research and Development Organisation (DRDO) | Grant |
| MedTech Innovator | Grant |
| MassChallenge Israel | Grant |
| Startup Odisha | Grant |
| Y Combinator | Grant |
| GoAhead Ventures | Pre Seed, Early Funding |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 27, 2025
Will showcase blood clotting technology at TechCrunch Disrupt 2025.
- Mar 31, 2022
$420K raised, led by GoAhead Ventures.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_awardNov 4, 2026
Miraqules receives the global grand prize in the Health and Biomedical category at SLINGSHOT 2026 in Singapore on Nov 4th '26.
For institutional investors. Book with your work email.
Miraqules Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Miraqules's valuation, stock price, and market status.
Is Miraqules a public or private company?
Miraqules is a private company.
What is the current stock price of Miraqules?
Miraqules is a private company, so its shares have no public market price. Caplight tracks Miraqules's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Miraqules worth (valuation)?
Miraqules's valuation is estimated at $1.8M based on funding round data.
Can I buy Miraqules stock?
Miraqules shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Miraqules's last funding round?
Miraqules's most recent funding round was Accelerator on July 10, 2023.
Who are the main investors in Miraqules?
Key investors in Miraqules include GoAhead Ventures.
Will Miraqules IPO soon?
No public IPO plans have been announced for Miraqules.
How can I track Miraqules secondary market activity?
Caplight tracks bids, offers, and trades in Miraqules's shares on secondary markets.